Steven W. Lefkowitz's most recent trade in CorMedix Inc was a trade of 30,453 Common Stock done . Disclosure was reported to the exchange on Jan. 26, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| CorMedix Inc | Steven W. Lefkowitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2026 | 30,453 | 125,951 (0%) | 0% | 0 | Common Stock | |
| CorMedix Inc | Steven W. Lefkowitz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.63 per share. | 12 Jan 2026 | 15,000 | 95,498 (0%) | 0% | 5.6 | 84,450 | Common Stock |
| CorMedix Inc | Steven W. Lefkowitz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2026 | 15,000 | 0 | - | - | Stock Option (Right to Buy Common Stock) | |
| CorMedix Inc | Steven W. Lefkowitz | Director | Sale of securities on an exchange or to another person at price $ 11.88 per share. | 09 Dec 2025 | 40,000 | 80,498 (0%) | 0% | 11.9 | 475,200 | Common Stock |
| CorMedix Inc | Steven W. Lefkowitz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Apr 2025 | 20,000 | 0 | - | - | Stock Option (Right to Buy Common Stock) | |
| CorMedix Inc | Steven W. Lefkowitz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.03 per share. | 02 Apr 2025 | 20,000 | 120,498 (0%) | 0% | 4.0 | 80,600 | Common Stock |
| CorMedix Inc | Steven W. Lefkowitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 25,000 | 100,498 (0%) | 0% | 0 | Common Stock | |
| CorMedix Inc | Steven W. Lefkowitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy Common Stock) | |
| CorMedix Inc | Steven W. Lefkowitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2023 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy Common Stock) | |
| CorMedix Inc | Steven W. Lefkowitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy Common Stock) |